Esma Selcuk

Esma Selcuk

Auto-generated profile, based on publicly available information

Esma Selcuk

Department of Medical Biology, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
OOOzlem Ozmen
Ozlem Ozmen
AMAdem MİLLETSEVER
Adem MİLLETSEVER
STSerife Tasan
Serife Tasan
ESEsma Selcuk
Esma Selcuk
MSMehtap Savran
Mehtap Savran
Methotrexate (MTX) is a widely used medication for various cancers, yet its use is associated with adverse effects on organs, notably the lungs. Cannabidiol (CBD), known for its antioxidant and anti-inflammatory properties, was investigated for its potential protective effects against MTX-induced lung injury. Thirty-two female Wistar Albino rats were divided into four groups: control, MTX (single 20 mg/kg intraperitoneal dose), MTX + CBD (single 20 mg/kg MTX with 0.1 ml of 5 mg/kg CBD for 7 days intraperitoneally) and CBD only (for 7 days). Lung tissues were analysed using histopathological, immunohistochemical and PCR methods after the study. Histopathological assessment of the MTX group revealed lung lesions like hyperemia, edema, inflammatory cell infiltration and epithelial cell loss. Immunohistochemical examination showed significant increases in Cas-3, tumour necrosis factor-alpha (TNF-alpha) and nuclear factor-kappa B (NF-kappa B) expressions. PCR analysis indicated elevated expressions of apoptotic peptidase activating factor 1 (Apaf 1), glucose-regulated protein 78 (GRP 78), CCAAT-enhancer-binding protein homologous protein (CHOP) and cytochrome C (Cyt C), along with reduced B-cell lymphoma-2 (BCL 2) expressions in the MTX group, though not statistically significant. Remarkably, CBD treatment reversed these findings. This study highlights CBD's potential in mitigating MTX-induced lung damage, suggesting its therapeutic promise.

12 March 2026 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Open access
PDF file
OUOnur Unal
Onur Unal
HAHalil Asci
Halil Asci
ESEsma Selcuk
Esma Selcuk
AMAdem Milletsever
Adem Milletsever
MTMuhammet Yusuf Tepebasi
Muhammet Yusuf Tepebasi
OOOzlem Ozmen
Ozlem Ozmen
This study investigated the protective effects of Gallic acid (GA) on Lipopolysaccharide (LPS)‐induced acute lung injury (ALI), focusing on inflammatory cytokines and barrier integrity markers through histopathological, immunohistochemical, and genetic evaluations. Thirty‐two adult male Wistar Albino rats were divided into Control, LPS, LPS + GA, and GA groups. LPS (5 mg/kg, intraperitoneal) induced ALI and GA (100 mg/kg, intraperitoneal) was administered to the treatment group. LPS caused hemorrhage, interalveolar septa thickening, inflammatory cell infiltration, and hyperemia. Interleukin (IL)‐1β, IL‐6, IL‐17A, and glycogen synthase kinase‐3 beta (GSK3β) increased, while IL‐10, aquaporin 2 (AQP2), zonula occludens 1 (ZO‐1), claudin 5 (Clau‐5), serine/threonine kinase 1 (AKT1), and nuclear factor erythroid 2–related factor 2 (NRF2) decreased. GA reduced tissue damage and pro‐inflammatory cytokines while restoring AKT1, NRF2, AQP2, ZO‐1, and Clau‐5. These findings suggest that GA attenuates LPS‐induced lung injury and is associated with modulation of inflammatory and antioxidant‐related signaling, including components of the IL‐10–AKT1/GSK3β/NRF2 axis.

17 March 2026 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
AKAlim Kosar
Alim Kosar
PKPinar Aslan Kosar
Pinar Aslan Kosar
MTMuhammet Yusuf Tepebasi
Muhammet Yusuf Tepebasi
HAHalil Asci
Halil Asci
IIIlter Ilhan
Ilter Ilhan
OOOzlem Ozmen
Ozlem Ozmen

27 March 2026 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
MKMUSTAFA KARACA
MUSTAFA KARACA
BBBurcu Bakir
Burcu Bakir
AIAybike Imeci
Aybike Imeci
ESEsma Selcuk
Esma Selcuk
HAHalil Asci
Halil Asci
OOOzlem Ozmen
Ozlem Ozmen
Methotrexate (MTX) commonly causes oral mucositis by inducing epithelial cytotoxicity and inflammation, leading to functional impairment and treatment limi

9 December 2025 in Scientific Reports
Verified
Journal Article
Open access
ESEMİNE SARMAN
EMİNE SARMAN
HAHalil Asci
Halil Asci
ESEsma Selcuk
Esma Selcuk
This study aimed to investigate the immunohistochemical expression patterns of proliferating cell nuclear antigen (PCNA), heat shock protein-70 (HSP-70), and kisspeptin-1 (KISS-1), as well as the gene expression levels of nuclear factor erythroid 2-related factor 2 (NRF2), heme oxygenase-1 (HO-1), tumor necrosis factor-alpha (TNF-α), and caspase-3 (CAS-3) in cisplatin (CIS)-induced ovarian toxicity, and to evaluate the protective effects of dapagliflozin (DAPA). Thirty-two female Wistar albino rats (n = 8 per group) were divided into four groups: Control, CIS (7.5 mg/kg, intraperitoneal), CIS + DAPA (10 mg/kg DAPA, oral for 7 days + CIS), and DAPA alone. Ovarian tissues were harvested for immunohistochemical and genetic evaluations. PCNA, HSP-70, and KISS-1 immunoreactivities were semi-quantitatively scored, and the mRNA expression levels of NRF2, HO-1, TNF-α, and CAS-3 were assessed using real-time quantitative PCR. All results were statistically analyzed. CIS administration led to a marked increase in PCNA, HSP-70, and KISS-1 immunoexpression, along with downregulation of NRF2 and HO-1 and upregulation of TNF-α and CAS-3 gene expressions (p < 0.001 for all) compared to the control group, indicating enhanced cellular proliferation, oxidative stress, inflammation, and apoptosis. In the CIS + DAPA group, a significant attenuation in PCNA (p < 0.001), HSP-70 (p < 0.001), and KISS-1 (p < 0.001) expression levels, and a reversal of genetic alterations were observed compared to the CIS group, demonstrating that DAPA mitigated proliferative, stress-associated, inflammatory, and apoptotic changes induced by CIS expressions (p < 0.001 for all). Ovarian tissues in the DAPA-alone group maintained expression profiles similar to the control. DAPA exerts protective effects against CIS-induced ovarian damage by modulating proliferation, cellular stress, inflammation, and apoptotic pathways, as evidenced by the downregulation of PCNA, HSP-70, KISS-1, TNF-α, and CAS-3, and upregulation of NRF2 and HO-1. These findings suggest that DAPA may offer a novel therapeutic approach for preserving ovarian function in patients undergoing chemotherapy.

28 April 2026 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Open access
PDF file
AEAbdulkerim Elmas
Abdulkerim Elmas
NKNasif Fatih Karakuyu
Nasif Fatih Karakuyu
HPHeybet Kerem Polat
Heybet Kerem Polat
ESEsma Selcuk
Esma Selcuk
OİOrhan İmeci
Orhan İmeci
MSMehtap Savran
Mehtap Savran
Aim: This study aimed to compare the therapeutic efficacy of a sulfasalazine-loaded thermoresponsive in-situ gel with orally administered sulfasalazine in an acetic acid–induced rat colitis model, focusing on mucosal healing, inflammatory regulation, and apoptotic pathways. Materials and methods: Colitis was induced in Wistar albino rats by intrarectal administration of 4% acetic acid. Animals were assigned to four groups: Control, Colitis, Colitis + Oral Sulfasalazine (100 mg/kg), and Colitis + In-Situ Gel. The in-situ gel was formulated with poloxamer 407, hyaluronic acid, and sulfasalazine. In vitro characterization included pH, gelation temperature, viscosity, rheology, and drug-release behavior. After 7 days of treatment, colon tissues were harvested for macroscopic, histopathological, and immunohistochemical analyses (Tumor necrosis factor alpha (TNF-α), Interleukin-1β (IL-1β), Caspase-3 (Cas-3)). Gene-expression profiles of Interleukin-6 (IL-6), Interleukin-10 (IL-10), Bcl-2 Associated X-protein (Bax), and B-Cell Leukemia/Lymphoma 2 (Bcl-2) were assessed via RT-qPCR. Results: In vitro studies confirmed optimal gelation behavior and sustained drug release. Oral and gel treatments both reduced epithelial injury; however, the in-situ gel produced markedly superior mucosal preservation, reduced inflammatory infiltration, and lower TNF-α, IL-1β, and Cas-3 immunoreactivity. Gene-expression analysis showed significant reductions in Bax and IL-6, within the gel group. Conclusions: Sulfasalazine-loaded in-situ gel demonstrated superior anti-inflammatory, anti-apoptotic, and mucosal reparative effects compared with oral sulfasalazine. These findings support thermoresponsive in-situ gels as a promising localized therapeutic strategy for ulcerative colitis.